Jiangsu Apon Medical Technology Co Ltd
Jiangsu Apon Medical Technology Co Ltd is a medical equipment and supplies company that generates revenue through the production and distribution of healthcare products.
Business. Jiangsu Apon Medical Technology Co Ltd (300753.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Jiangsu Apon Medical Technology Co Ltd (300753.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Jiangsu Apon Medical Technology Co Ltd has a market capitalization of 2.9999 billion CNY and a price-to-book ratio of 4.49, indicating a premium valuation relative to its book value. The company's liquidity position is characterized as medium, with a current ratio of 2.59, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -23.997 million CNY, and its operating cash flow is only 2.333 million CNY, indicating limited cash generation from operations.
Profitability metrics show a challenging financial position for the company. The return on equity is -3.6%, and the return on assets is -2.79%, both significantly below the industry median for medical equipment and supplies firms. The company reported a net loss of 24.021 million CNY and an operating loss of 27.005 million CNY, reflecting a decline in profitability. Gross profit of 231.619 million CNY is a positive sign, but it is insufficient to offset the operating and net losses.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases the company's exposure to market-specific risks, particularly in the healthcare equipment and supplies industry. The absence of segment-specific revenue data limits the ability to assess the performance of individual product lines or geographic regions.
Looking ahead, the company's growth trajectory is uncertain. The provided data does not include specific revenue growth projections for the current or next fiscal year. However, the company's negative net income and operating income suggest a need for strategic improvements to drive profitability and revenue growth. The capital expenditure of -8.435 million CNY indicates some investment in infrastructure, but the scale is relatively small compared to the company's total assets.
The company's risk profile includes a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash position after subtracting total debt, which could impact the company's ability to meet short-term obligations. The debt-to-equity ratio of 0.18 suggests a conservative capital structure, with limited leverage. However, the company's negative free cash flow and operating cash flow indicate potential challenges in maintaining financial flexibility.
Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The absence of recent transcripts or filings limits the ability to assess the company's management's outlook and plans for addressing its financial challenges. The company's financial performance and risk profile suggest a need for close monitoring of its operational and financial strategies to ensure long-term sustainability.
- Jiangsu Apon Medical Technology Co Ltd is a medical equipment and supplies company with a market capitalization of 2.9999 billion CNY.
- The company has a price-to-book ratio of 4.49 and a current ratio of 2.59, indicating a premium valuation and sufficient short-term liquidity.
- The company reported a net loss of 24.021 million CNY and an operating loss of 27.005 million CNY, reflecting a decline in profitability.
- The company's revenue is concentrated in a single business segment, increasing its exposure to market-specific risks.
- The company's risk profile includes a medium liquidity risk and a low dilution risk, with a key financial flag being the negative net cash position after subtracting total debt.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Jiangsu Apon Medical Technology Co Ltd Market data — financials · 2026-05-26